(NASDAQ:ARQT), Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2 ZORYVE cream 0.05% provides rapid clearance of atopic dermatitis ZORYVE can be used anywhere on the body for any duration and is not a steroid Atopic dermatitis is the most common type of eczema, affecting approximately […]
(TSX-V:SGO),(OTC US:SMOFF),(Other OTC:SMOFF),(Boerse Frankfurt – Freiverkehr:23SP.F),(Boerse Frankfurt – Freiverkehr:23SP), VANCOUVER, Canada, Oct. 30, 2025 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce the Company has made the final concession payment on its flagship Cerro Caliche gold project in Sonora, Mexico. In
(NASDAQ:RARE), NOVATO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the first patient has been dosed in the Aurora study (NCT07157254) evaluating the efficacy and safety of GTX-102 (apazunersen), an investigational antisense oligonucleotide (ASO) for Angelman syndrome (AS). Data from the Aurora study will expand the population of
SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Wedbush Securities, a full-service financial services firm, today announced that Richard “Rick” Sherlund, one of Wall Street's most respected technology bankers and research analysts, and his team at Sherlund Partners LLC have joined in partnership with Wedbush's Disruptive Technology, Media & Sports investment banking group. Rick will
(NASDAQ:CELU),(NASDAQ:CELUW), FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, announced today a strategic partnership with DefEYE, Inc. (“DefEYE”), a newly established ophthalmic product and technology company. Celularity has executed an exclusive license & pricing arrangement with DefEYE on
(NASDAQ:BMEA), SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ObesityWeek(R) 2025, taking place November 4-7, 2025 in Atlanta, Georgia. The presentations will highlight preclinical data for BMF-650, Biomea's next-generation oral small molecule
(NasdaqGM:CSLR),(NasdaqGM:SPWR),(NASDAQ:SPWRW), OREM, Utah, Oct. 30, 2025 (GLOBE NEWSWIRE) — SunPower Inc. (Nasdaq: SPWR) a solar technology, services, and installation company, this morning announced the successful integration of the Sunder salesforce into the company — as SunPower continues to execute on plan and expects to achieve record revenue of $83.3 million and record operating income of
LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) — Altanine, a health innovation company dedicated to improving the comfort and convenience of everyday medicines through advanced formulation and delivery technologies, today announced the appointment of Dr. Bruce D. Forrest, MD, MBA, to its Scientific Advisory Board (SAB). This addition is a significant step as Altanine scales
(NASDAQ:WKHS), CINCINNATI, Oct. 30, 2025 (GLOBE NEWSWIRE) — Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reminded shareholders to take action and vote FOR all proposals in connection with Workhorse's upcoming 2025 Annual General Meeting of Shareholders (the “Annual Meeting”).
SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Cloudbrink, a leader in high-performance secure connectivity, today announced a breakthrough platform designed to solve one of the most pressing challenges in enterprise tech: how to bring AI safely and efficiently into the enterprise without compromising compliance or performance. The Cloudbrink AI platform is an AI-ready personal